Search
SectionsIndex
  • Behavior
  • Circulatory System
  • Clinical Pathology and Procedures
  • Digestive System
  • Emergency Medicine and Critical Care
  • Endocrine System
  • Exotic and Laboratory Animals
  • Eye and Ear
  • Generalized Conditions
  • Immune System
  • Integumentary System
  • Management and Nutrition
  • Metabolic Disorders
  • Musculoskeletal System
  • Nervous System
  • Pharmacology
  • Poultry
  • Reproductive System
  • Respiratory System
  • Toxicology
  • Urinary System
  • Zoonoses
ABCDEFGHI
JKLMNOPQR
STUVWXYZ
In This Topic
Pharmacology
Systemic Pharmacotherapeutics of the Urinary System
Urine Retention
Back to Top
Resources
  • About The Merck Veterinary Manual
  • Reference Guides
  • Multimedia
Manuals available online
'/home/index.html' + bookPageLink
 
'/vet/index.html'
These and other Manuals available
in print, online, and as mobile applications.

See more at MerckManuals.com
Sections in Veterinary Professionals
  • Behavior
  • Circulatory System
  • Clinical Pathology and Procedures
  • Digestive System
  • Emergency Medicine and Critical Care
  • Endocrine System
  • Exotic and Laboratory Animals
  • Eye and Ear
  • Generalized Conditions
  • Immune System
  • Integumentary System
  • Management and Nutrition
  • Metabolic Disorders
  • Musculoskeletal System
  • Nervous System
  • Pharmacology
  • Poultry
  • Reproductive System
  • Respiratory System
  • Toxicology
  • Urinary System
  • Zoonoses
Chapters in Pharmacology
  • Pharmacology Introduction
  • Systemic Pharmacotherapeutics of the Cardiovascular System
  • Systemic Pharmacotherapeutics of the Digestive System
  • Systemic Pharmacotherapeutics of the Eye
  • Systemic Pharmacotherapeutics of the Integumentary System
  • Systemic Pharmacotherapeutics of the Muscular System
  • Systemic Pharmacotherapeutics of the Nervous System
  • Systemic Pharmacotherapeutics of the Reproductive System
  • Systemic Pharmacotherapeutics of the Respiratory System
  • Systemic Pharmacotherapeutics of the Urinary System
  • Chemotherapeutics Introduction
  • Anthelmintics
  • Antibacterial Agents
  • Antifungal Agents
  • Anti-Inflammatory Agents
  • Antineoplastic Agents
  • Antiseptics and Disinfectants
  • Antiviral Agents and Biologic Response Modifiers
  • Ectoparasiticides
  • Growth Promotants and Production Enhancers
  • Vaccines and Immunotherapy
Topics in Systemic Pharmacotherapeutics of the Urinary System
  • Overview of Systemic Pharmacotherapeutics of the Urinary System
  • Bacterial Urinary Tract Infections
  • Fungal Urinary Tract Infections
  • Diuretics
  • Dopamine in Urinary Disease
  • Glomerular Disease
  • Diabetes Insipidus
  • Controlling Urine pH
  • Cystine-binding Agents in Urinary Disease
  • Urinary Incontinence
  • Urine Retention
 
  • Merck Manual
  • >
  • Veterinary Professionals
  • >
  • Pharmacology
  • >
  • Systemic Pharmacotherapeutics of the Urinary System
  • 4
 
Urine Retention

Share This

Disorders of micturition characterized by urine retention and a distended bladder are usually caused by hypocontractility of the bladder or by urethral obstruction. Prolonged bladder distention leads to breakdown of the tight junctions between detrusor muscle cells of the bladder, which prevents normal depolarization and contraction of the detrusor muscles.

An adrenergic antagonist may be indicated when manual expression or voluntary voiding is nonproductive because urethral sphincter tone is excessive, as is often the case in cats after relief of obstruction. Phenoxybenzamine, an irreversible antagonist, has been used with some success. The dosage for dogs or cats is 0.25 mg/kg, PO, bid.

Diazepam is a benzodiazepine anxiolytic that is also a central muscle relaxant. Dosages sufficient to allow for urethral relaxation may also cause sedation. The dosage in dogs is 0.2 mg/kg, PO, tid, and in cats is 0.5 mg/kg, IV. Diazepam given PO may cause idiosyncratic acute hepatic necrosis in cats.

In animals with detrusor hyporeflexia or bladder atony, bethanechol chloride may be of some benefit. This cholinergic agonist stimulates the initiation of detrusor muscle contraction. The dosage for dogs is 5–25 mg/dog, PO, tid, and for cats is 2.5–7.5 mg/cat, PO, tid.

Last full review/revision March 2012 by Patricia M. Dowling, DVM,MSc, DACVIM, DACVCP

Buy the Book

Back to Top

Previous: Urinary Incontinence

Next: Overview of Chemotherapeutics

Audio
Figures
Photographs
Sidebars
Tables
Videos

Copyright     © 2010-2013 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, N.J., U.S.A.    Privacy    Terms of Use